J&J Loses Third Trial Over Cancer Link to Talcum Powder
- Jurors return $70 million verdict after 3 hours deliberations
- Company denies link between talcum powder use, ovarian cancer
This article is for subscribers only.
Johnson & Johnson lost a third straight trial over claims its talcum powder can cause ovarian cancer with a St. Louis jury awarding a California woman more than $70 million.
J&J is accused in about 1,700 lawsuits in state and federal court of ignoring studies linking its baby powder and Shower-to-Shower talc products to ovarian cancer and failing to warn customers about the risk. Thursday’s verdict follows damages verdicts of $72 million and $55 million against the company this year in the first two talc claims to go to trial in St. Louis. Both are being appealed.